Increasing Prevalence of Chronic Disorders in North America to Drive Global Cell & Gene Therapy Drug Delivery Devices Market through 2028

According to MarkNtel Advisors, the Global Cell & Gene Therapy Drug Delivery Devices Market is projected to witness around 14% CAGR during 2021-28. The market is driven primarily by the surging incidence of chronic diseases & genetic disorders, massive investments by numerous conglomerate companies & startups in developing advanced cell & gene therapy procedures, and the rapidly increasing FDA approvals for therapies & clinical trials.

Get a sample copy of the market research: https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html

Market Segmentation
1. By Product Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe (Size 1.0 ML, 31-Gauge Needle), (Size 0.5 ML, 22-Gauge Needle)), Pre-Filled Syringe (Size 1.0 ML, 22-26 Gauge Needle), (Size 4.0 ML, 22-26 Gauge Needle)), Infusion Bags (Size 10 ML to 50 ML), (Size 68 ML), (Size 60 ML), (Size Up to 65 ML))
2. By Technology (Microchip Technology, Nano-Technology, Lipid Nanoparticles)
3. By Commercialized Drugs (Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis)
4. By End-Users (Pharmaceuticals & Biotechnology Company, Academic & Research Institute, Hospitals & Clinics)

For detailed analysis: https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Region-Wise Segmentation
• North America: US, Canada, Mexico
• South America: Brazil, Argentina
• Europe: The UK, Germany, France, Spain, Italy
• Asia-Pacific: China, India, Japan, South Korea
• Middle East & Africa: UAE, Saudi Arabia, Israel, Qatar, South Africa

Key Growth Drivers
• Massive investments in pharmaceutical R&D, particularly across the US, for the development of new & improved cell & gene therapies
• Growing incidence of chronic diseases & genetic disorders
• Burgeoning FDA approvals for clinical trials of cell & gene therapies

Possible Growth Challenge
• high manufacturing costs of cell & gene therapies

Share your requirements: https://www.marknteladvisors.com/query/request-customization/cell-gene-therapy-drug-delivery-devices-market.html

Market Competitors:
Amgen Inc., Bausch & Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio Inc., Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.), Dendreon Pharmaceuticals LLC, Helixmith Co. Ltd (ViroMed Co., Ltd), Human Stem Cells Institute, Kite Pharma Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer Inc., Renova Therapeutics, Spark Therapeutics Inc., uniQure N.V., Vericel Corporation

Key Questions Answered in this Report:
1. What are the current & future trends in the Global Cell & Gene Therapy Drug Delivery Devices Market?
2. What are the overall statistics or estimates (Overview, Size- by Value, Forecast Numbers, Segmentation, and Shares) of the Global Cell & Gene Therapy Drug Delivery Devices Market?
3. How has the industry been evolving in terms of geography & service adoption?
4. How has the competition been shaping across the globe, followed by their comparative factorial indexing?
5. What are the key growth drivers & challenges for the Global Cell & Gene Therapy Drug Delivery Devices Market?
6. What are the customer orientation, purchase behavior, and expectations from cell & gene therapy drug delivery device manufacturers across the globe?
7. What is the region-wise industry size, growth drivers, and challenges?
8. What are the key innovations, opportunities, current & future trends, and regulations in the Global Cell & Gene Therapy Drug Delivery Devices Market?
9. Who are the key competitors, their key strengths & weaknesses, and how do they perform in the Global Cell & Gene Therapy Drug Delivery Devices Market based on a competitive benchmarking matrix?
10. What are the key results derived from the surveys conducted during the Global Cell & Gene Therapy Drug Delivery Devices Market study?

MarkNtel Advisors
1147 88AVE, Delta, British Columbia, BC,V4C,3B8, CANADA
Email: sales@marknteladvisors.com
Tel: +1 604 800 2671
Website: https://www.marknteladvisors.com

About us:
MarkNtel Advisors is a leading research, consulting and data analytics firm that provides a wide range of strategic reports on diverse industry verticals to a substantial and varied client base that includes multinational corporations, financial institutions, governments, and individuals.

We specialize in niche industries and emerging geographies to support our clients in the formulation of strategies viz. Go to Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, trend analysis, etc. in around 15 industry verticals to enable our clients in identifying attractive investment opportunities and maximizing ROI through an early mover advantage.

This release was published on openPR.